09:50 AM EST - Cipher Pharmaceuticals Inc. : announced it has entered into a definitive distribution and supply agreement with Ranbaxy Laboratories Ltd. under which Cipher has granted Ranbaxy the exclusive right to market, sell and distribute Cipher's isotretinoin capsules in Brazil. This agreement extends the current relationship with Ranbaxy, which markets and distributes Cipher's isotretinoin product in the United States under the brand Absorica™. Cipher Pharmaceuticals Inc.
shares T.DND are trading up $0.12 at $9.18.
